Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate at 10 uM preincubated for 10 mins followed by NADPH addition and measured after 15 mins by LC-MS/MS analysis
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of CYP2C19 in human liver microsomes using S-mephenytoin as substrate at 10 uM preincubated for 10 mins followed by NADPH addition and measured after 15 mins by LC-MS/MS analysis
Inhibition of CYP2C8 (unknown origin)
Inhibition of CYP2C9 (unknown origin)
Assay data:1 Active, 3 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of CYP2C19 (unknown origin)
Assay data:3 Tested
Assay data:1 Active, 1 Tested
Inhibition of CYP2C9 in human liver microsomes incubated for 10 mins in presence of NADPH by LC/MS/MS analysis
Assay data:2 Tested
Reversible inhibition of CYP2C19 in human liver microsomes assessed as residual activity at 5 uM using (S)-mephenytoin as substrate preincubated for 30 mins followed by substrate addition measured after 20 mins by LC-MS/MS analysis relative to control
Reversible inhibition of CYP2C9 in human liver microsomes assessed as residual activity at 5 uM using diclofenac as substrate preincubated for 30 mins followed by substrate addition measured after 20 mins by LC-MS/MS analysis relative to control
Assay data:4 Tested
Reversible inhibition of CYP2C8 in human liver microsomes assessed as residual activity at 5 uM using amodiaquine as substrate preincubated for 30 mins followed by substrate addition measured after 20 mins by LC-MS/MS analysis relative to control
Inhibition of human CYP2C8
Assay data:1 Active, 2 Tested
Inhibition of human CYP2C9
Assay data:2 Active, 2 Tested
Inhibition of human CYP2C19
Assay data:2 Active, 1 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Assay data:5 Active, 2 Activity ≤ 1 µM, 5 Tested
Assay data:8 Active, 1 Activity ≤ 1 µM, 9 Tested
Inhibition of CYP2C19 in human liver microsomes
Inhibition of CYP2C9 in human liver microsomes
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on